A detailed history of Assenagon Asset Management S.A. transactions in Amgen Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,539,733 shares of AMGN stock, worth $406 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
1,539,733
Previous 232,751 561.54%
Holding current value
$406 Million
Previous $72.7 Million 582.2%
% of portfolio
1.04%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $404 Million - $441 Million
1,306,982 Added 561.54%
1,539,733 $496 Million
Q2 2024

Jul 18, 2024

SELL
$262.75 - $319.31 $82.8 Million - $101 Million
-314,982 Reduced 57.51%
232,751 $72.7 Million
Q1 2024

Apr 24, 2024

SELL
$268.87 - $324.56 $94.5 Million - $114 Million
-351,499 Reduced 39.09%
547,733 $156 Million
Q4 2023

Jan 17, 2024

BUY
$255.7 - $288.46 $191 Million - $215 Million
745,929 Added 486.57%
899,232 $259 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $26 Million - $32.3 Million
119,124 Added 348.53%
153,303 $41.2 Million
Q2 2023

Jul 25, 2023

SELL
$214.27 - $253.37 $32.3 Million - $38.2 Million
-150,752 Reduced 81.52%
34,179 $7.59 Million
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $22.8 Million - $27.8 Million
101,181 Added 120.81%
184,931 $44.7 Million
Q4 2022

Jan 12, 2023

SELL
$229.03 - $291.01 $6.89 Million - $8.76 Million
-30,100 Reduced 26.44%
83,750 $22 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $24.1 Million - $27.2 Million
107,416 Added 1669.51%
113,850 $25.7 Million
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $57,908 - $64,441
-251 Reduced 3.75%
6,434 $1.57 Million
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $10,086 - $11,158
46 Added 0.69%
6,685 $1.62 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $1.42 Million - $1.63 Million
-7,140 Reduced 51.82%
6,639 $1.49 Million
Q3 2021

Oct 19, 2021

BUY
$212.27 - $248.7 $1.31 Million - $1.54 Million
6,192 Added 81.61%
13,779 $2.93 Million
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $36,905 - $40,944
158 Added 2.13%
7,587 $1.85 Million
Q1 2021

Apr 26, 2021

SELL
$221.91 - $258.6 $5,325 - $6,206
-24 Reduced 0.32%
7,429 $1.85 Million
Q4 2020

Feb 01, 2021

BUY
$216.38 - $257.67 $511,305 - $608,874
2,363 Added 46.42%
7,453 $1.71 Million
Q3 2020

Oct 07, 2020

SELL
$234.65 - $260.95 $301,994 - $335,842
-1,287 Reduced 20.18%
5,090 $1.29 Million
Q2 2020

Jul 21, 2020

BUY
$197.81 - $242.74 $811,614 - $995,962
4,103 Added 180.43%
6,377 $1.5 Million
Q1 2020

Apr 17, 2020

BUY
$182.24 - $241.7 $414,413 - $549,625
2,274 New
2,274 $461,000
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $22.3 Million - $28.7 Million
-117,813 Closed
0 $0
Q3 2019

Oct 16, 2019

SELL
$174.11 - $208.62 $59.5 Million - $71.4 Million
-342,018 Reduced 74.38%
117,813 $22.8 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $64.5 Million - $75.6 Million
387,081 Added 532.07%
459,831 $84.7 Million
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $3.54 Million - $3.98 Million
19,545 Added 36.74%
72,750 $13.8 Million
Q4 2018

Jan 23, 2019

SELL
$178.4 - $208.25 $36.9 Million - $43 Million
-206,705 Reduced 79.53%
53,205 $10.4 Million
Q3 2018

Oct 29, 2018

SELL
$185.29 - $208.89 $21.9 Million - $24.7 Million
-118,270 Reduced 31.27%
259,910 $53.9 Million
Q2 2018

Jul 17, 2018

BUY
$166.05 - $186.51 $49 Million - $55 Million
294,990 Added 354.6%
378,180 $69.8 Million
Q1 2018

Apr 30, 2018

SELL
$169.43 - $198.0 $3.33 Million - $3.89 Million
-19,647 Reduced 19.1%
83,190 $14.2 Million
Q4 2017

Jan 25, 2018

BUY
$168.79 - $188.59 $4.3 Million - $4.8 Million
25,446 Added 32.88%
102,837 $17.9 Million
Q3 2017

Oct 18, 2017

BUY
$167.29 - $191.0 $12.9 Million - $14.8 Million
77,391
77,391 $14.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.